Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

SAULT TRIBE OF CHIPPEWA INDIANS

NPI: 1750434395 · SAULT SAINTE MARIE, MI 49783 · Clinical Medical Laboratory · NPI assigned 01/18/2007

$515K
Total Medicaid Paid
42,631
Total Claims
42,106
Beneficiaries
45
Codes Billed
2018-01
First Month
2024-09
Last Month

Provider Details

Authorized OfficialCULFA, BONNIE (HEALTH DIRECTOR)
Parent OrganizationSAULT TRIBE OF CHIPPEWA INDIANS
NPI Enumeration Date01/18/2007

Related Entities

Other providers sharing the same authorized official: CULFA, BONNIE

ProviderCityStateTotal Paid
SAULT TRIBE OF CHIPPEWA INDIANS SAULT SAINTE MARIE MI $18.55M
SAULT TRIBE OF CHIPPEWA INDIANS SAULT SAINTE MARIE MI $5.93M
SAULT TRIBE OF CHIPPEWA INDIANS SAULT SAINTE MARIE MI $1.67M
SAULT TRIBE OF CHIPPEWA INDIANS SAULT SAINTE MARIE MI $1.46M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 5,177 $59K
2019 4,865 $59K
2020 4,908 $61K
2021 7,008 $88K
2022 7,608 $89K
2023 8,224 $99K
2024 4,841 $59K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 3,603 3,585 $90K
84443 Thyroid stimulating hormone (TSH) 4,351 4,300 $59K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 304 304 $49K
80053 Comprehensive metabolic panel 5,296 5,216 $48K
80061 Lipid panel 3,677 3,666 $41K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 6,361 6,251 $41K
83036 Hemoglobin; glycosylated (A1C) 4,331 4,313 $35K
84439 2,447 2,423 $19K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 367 360 $18K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 504 489 $15K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 489 475 $15K
82607 1,159 1,156 $14K
82746 997 994 $12K
83735 1,629 1,606 $9K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 181 179 $8K
81001 1,930 1,893 $5K
87088 617 598 $4K
84466 403 399 $4K
87081 660 651 $4K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 178 178 $4K
83540 696 693 $4K
83655 322 319 $3K
80048 Basic metabolic panel (calcium, ionized) 381 373 $3K
82728 189 189 $2K
87086 Culture, bacterial; quantitative colony count, urine 196 191 $1K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 51 51 $1K
83970 29 29 $957.79
86703 73 72 $893.24
82570 213 198 $795.61
86803 68 67 $794.69
87070 106 104 $747.69
87077 94 82 $703.88
81025 70 67 $454.68
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 14 14 $448.00
84146 24 24 $384.96
87186 25 24 $173.05
82180 16 16 $131.04
82043 27 26 $124.28
82310 32 30 $123.23
80076 16 14 $112.80
85652 27 26 $69.24
82248 16 16 $66.56
85027 12 12 $64.20
36415 Collection of venous blood by venipuncture 437 420 $2.70
83519 13 13 $0.00